Q2-osavuosiraportti
80 päivää sitten‧45 min
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
15 234
Myynti
Määrä
112 014
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 129 | - | - | ||
| 316 | - | - | ||
| 13 745 | - | - | ||
| 255 | - | - | ||
| 484 | - | - |
Ylin
0,32VWAP
Alin
0,296VaihtoMäärä
1,5 4 958 215
VWAP
Ylin
0,32Alin
0,296VaihtoMäärä
1,5 4 958 215
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q3-osavuosiraportti | 26.11. |
| Menneet tapahtumat | ||
|---|---|---|
| Merkintäoikeusanti | 2.10. | |
| 2025 Ylimääräinen yhtiökokous | 29.9. | |
| 2025 Q2-osavuosiraportti | 28.8. | |
| 2025 Q1-osavuosiraportti | 14.5. | |
| 2024 Yhtiökokous | 14.5. |
Datan lähde: Millistream, Quartr
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·10 t sitten · MuokattuCool. Norway. Blood test for Alzheimer's, 90 % certainty, was launched at Akershus University Hospital (AHUS) last Monday. The age limit is set to 50 years. Congratulations. I see certain similarities with PancreaSure in this. Despite them being different blood tests, I cannot see that they state what Norway pays per blood test. Furthermore, it states in the article, which also seems to show certain similarities: "He says it can also open up possibilities for direct, targeted treatment against the condition for those who do not have Alzheimer's disease, but other conditions with cognitive changes, mental changes, before dementia. – Today, we only diagnose a very small proportion of patients who later develop dementia, at pre-dementia stages. And then nothing can be done about this progression, says Fladby." "Fladby says the innovation is also important from a societal perspective." https://www.nrk.no/trondelag/ny-blodprove-kan-pavise-alzheimers-sykdom-1.17653022- ·1 päivä sitten · MuokattuPure speculation. Is it those short traders who have held their short position the longest who now don't dare to hold for 2 days over the weekend plus market opening on Monday 😅 Hope they soon get burned. Literally (Icarus became too eager, and fell to his death according to the saga)
- ·1 päivä sittenExcuse me, but after the tough days of the share issue, I think we are in an incredibly exciting phase. Everything seems flat now for 2-3 days. This is much better than the short trading pressure there has been. The price has settled at 30 øre. Probably a "safe guard"-like price. In reality, this is incredibly low. And probably very cheap given this a few weeks ahead. That's the perspective I envision. Everyone is waiting for Q3. Even though such trading volumes would normally be seen as either unhealthy or alternatively as a micro-company. Yes, Immunovia AB can actually be compared to a micro-company at the moment, just with possibilities for an enormous upside given that they have a product that works? They also have a product that can be thought of as quite unique, and which should be sought after by health authorities in many countries around the world. That's what I believe in. Give this 2026-2027 "then we go". Give it some further unknown number of years, then we really go? We haven't gone through the share issue for fun. Everyone wants a little profit, right? A little good news and it will rise, right? Just news, I think, helps in itself now, so could it be?·1 päivä sitten · MuokattuAnother way to look at this. Good that there's no profit to be made at 30 öre 😜 Which way does it go then?
- ·2 päivää sitten · MuokattuIf this is true about short trading? Yes, at least we are not rising with heavy short trading as there has been. But a quiet period now. Good sign. https://forum.placera.se/inlagg/2eb1cb40-7488-4e6d-acdf-0cdc3d899853 It doesn't take much more than news that doctors prescribe the blood test. That is the signal that should matter. Increased confidence signal for the blood test. Sales figures will be marginal, I think. Even Borcherdinger has said that it will be lean in the first few months. This was already said in the days around the PancreaSure launch. Honest and serious. All news about building trust is what matters now. Profit will eventually come later, if this goes very well.
·2 päivää sittenContinued strong selling pressure for some reason, a little positive news is needed from the company/Jeff·1 päivä sittenIt seems strange that short selling would vary so much without significant impact on the price... could it rather have something to do with the conversion from BTA to shares, as short selling can only be done with shares and now the number of shares has increased?·1 päivä sittenIsn't it just different brokerage houses' fault then? Someone mentioned SEB as slow. Here at Nordnet it went super fast.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Q2-osavuosiraportti
80 päivää sitten‧45 min
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·10 t sitten · MuokattuCool. Norway. Blood test for Alzheimer's, 90 % certainty, was launched at Akershus University Hospital (AHUS) last Monday. The age limit is set to 50 years. Congratulations. I see certain similarities with PancreaSure in this. Despite them being different blood tests, I cannot see that they state what Norway pays per blood test. Furthermore, it states in the article, which also seems to show certain similarities: "He says it can also open up possibilities for direct, targeted treatment against the condition for those who do not have Alzheimer's disease, but other conditions with cognitive changes, mental changes, before dementia. – Today, we only diagnose a very small proportion of patients who later develop dementia, at pre-dementia stages. And then nothing can be done about this progression, says Fladby." "Fladby says the innovation is also important from a societal perspective." https://www.nrk.no/trondelag/ny-blodprove-kan-pavise-alzheimers-sykdom-1.17653022
- ·1 päivä sitten · MuokattuPure speculation. Is it those short traders who have held their short position the longest who now don't dare to hold for 2 days over the weekend plus market opening on Monday 😅 Hope they soon get burned. Literally (Icarus became too eager, and fell to his death according to the saga)
- ·1 päivä sittenExcuse me, but after the tough days of the share issue, I think we are in an incredibly exciting phase. Everything seems flat now for 2-3 days. This is much better than the short trading pressure there has been. The price has settled at 30 øre. Probably a "safe guard"-like price. In reality, this is incredibly low. And probably very cheap given this a few weeks ahead. That's the perspective I envision. Everyone is waiting for Q3. Even though such trading volumes would normally be seen as either unhealthy or alternatively as a micro-company. Yes, Immunovia AB can actually be compared to a micro-company at the moment, just with possibilities for an enormous upside given that they have a product that works? They also have a product that can be thought of as quite unique, and which should be sought after by health authorities in many countries around the world. That's what I believe in. Give this 2026-2027 "then we go". Give it some further unknown number of years, then we really go? We haven't gone through the share issue for fun. Everyone wants a little profit, right? A little good news and it will rise, right? Just news, I think, helps in itself now, so could it be?·1 päivä sitten · MuokattuAnother way to look at this. Good that there's no profit to be made at 30 öre 😜 Which way does it go then?
- ·2 päivää sitten · MuokattuIf this is true about short trading? Yes, at least we are not rising with heavy short trading as there has been. But a quiet period now. Good sign. https://forum.placera.se/inlagg/2eb1cb40-7488-4e6d-acdf-0cdc3d899853 It doesn't take much more than news that doctors prescribe the blood test. That is the signal that should matter. Increased confidence signal for the blood test. Sales figures will be marginal, I think. Even Borcherdinger has said that it will be lean in the first few months. This was already said in the days around the PancreaSure launch. Honest and serious. All news about building trust is what matters now. Profit will eventually come later, if this goes very well.
- ·2 päivää sittenContinued strong selling pressure for some reason, a little positive news is needed from the company/Jeff·1 päivä sittenIt seems strange that short selling would vary so much without significant impact on the price... could it rather have something to do with the conversion from BTA to shares, as short selling can only be done with shares and now the number of shares has increased?·1 päivä sittenIsn't it just different brokerage houses' fault then? Someone mentioned SEB as slow. Here at Nordnet it went super fast.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
15 234
Myynti
Määrä
112 014
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 129 | - | - | ||
| 316 | - | - | ||
| 13 745 | - | - | ||
| 255 | - | - | ||
| 484 | - | - |
Ylin
0,32VWAP
Alin
0,296VaihtoMäärä
1,5 4 958 215
VWAP
Ylin
0,32Alin
0,296VaihtoMäärä
1,5 4 958 215
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q3-osavuosiraportti | 26.11. |
| Menneet tapahtumat | ||
|---|---|---|
| Merkintäoikeusanti | 2.10. | |
| 2025 Ylimääräinen yhtiökokous | 29.9. | |
| 2025 Q2-osavuosiraportti | 28.8. | |
| 2025 Q1-osavuosiraportti | 14.5. | |
| 2024 Yhtiökokous | 14.5. |
Datan lähde: Millistream, Quartr
Q2-osavuosiraportti
80 päivää sitten‧45 min
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q3-osavuosiraportti | 26.11. |
| Menneet tapahtumat | ||
|---|---|---|
| Merkintäoikeusanti | 2.10. | |
| 2025 Ylimääräinen yhtiökokous | 29.9. | |
| 2025 Q2-osavuosiraportti | 28.8. | |
| 2025 Q1-osavuosiraportti | 14.5. | |
| 2024 Yhtiökokous | 14.5. |
Datan lähde: Millistream, Quartr
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·10 t sitten · MuokattuCool. Norway. Blood test for Alzheimer's, 90 % certainty, was launched at Akershus University Hospital (AHUS) last Monday. The age limit is set to 50 years. Congratulations. I see certain similarities with PancreaSure in this. Despite them being different blood tests, I cannot see that they state what Norway pays per blood test. Furthermore, it states in the article, which also seems to show certain similarities: "He says it can also open up possibilities for direct, targeted treatment against the condition for those who do not have Alzheimer's disease, but other conditions with cognitive changes, mental changes, before dementia. – Today, we only diagnose a very small proportion of patients who later develop dementia, at pre-dementia stages. And then nothing can be done about this progression, says Fladby." "Fladby says the innovation is also important from a societal perspective." https://www.nrk.no/trondelag/ny-blodprove-kan-pavise-alzheimers-sykdom-1.17653022
- ·1 päivä sitten · MuokattuPure speculation. Is it those short traders who have held their short position the longest who now don't dare to hold for 2 days over the weekend plus market opening on Monday 😅 Hope they soon get burned. Literally (Icarus became too eager, and fell to his death according to the saga)
- ·1 päivä sittenExcuse me, but after the tough days of the share issue, I think we are in an incredibly exciting phase. Everything seems flat now for 2-3 days. This is much better than the short trading pressure there has been. The price has settled at 30 øre. Probably a "safe guard"-like price. In reality, this is incredibly low. And probably very cheap given this a few weeks ahead. That's the perspective I envision. Everyone is waiting for Q3. Even though such trading volumes would normally be seen as either unhealthy or alternatively as a micro-company. Yes, Immunovia AB can actually be compared to a micro-company at the moment, just with possibilities for an enormous upside given that they have a product that works? They also have a product that can be thought of as quite unique, and which should be sought after by health authorities in many countries around the world. That's what I believe in. Give this 2026-2027 "then we go". Give it some further unknown number of years, then we really go? We haven't gone through the share issue for fun. Everyone wants a little profit, right? A little good news and it will rise, right? Just news, I think, helps in itself now, so could it be?·1 päivä sitten · MuokattuAnother way to look at this. Good that there's no profit to be made at 30 öre 😜 Which way does it go then?
- ·2 päivää sitten · MuokattuIf this is true about short trading? Yes, at least we are not rising with heavy short trading as there has been. But a quiet period now. Good sign. https://forum.placera.se/inlagg/2eb1cb40-7488-4e6d-acdf-0cdc3d899853 It doesn't take much more than news that doctors prescribe the blood test. That is the signal that should matter. Increased confidence signal for the blood test. Sales figures will be marginal, I think. Even Borcherdinger has said that it will be lean in the first few months. This was already said in the days around the PancreaSure launch. Honest and serious. All news about building trust is what matters now. Profit will eventually come later, if this goes very well.
- ·2 päivää sittenContinued strong selling pressure for some reason, a little positive news is needed from the company/Jeff·1 päivä sittenIt seems strange that short selling would vary so much without significant impact on the price... could it rather have something to do with the conversion from BTA to shares, as short selling can only be done with shares and now the number of shares has increased?·1 päivä sittenIsn't it just different brokerage houses' fault then? Someone mentioned SEB as slow. Here at Nordnet it went super fast.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
15 234
Myynti
Määrä
112 014
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 129 | - | - | ||
| 316 | - | - | ||
| 13 745 | - | - | ||
| 255 | - | - | ||
| 484 | - | - |
Ylin
0,32VWAP
Alin
0,296VaihtoMäärä
1,5 4 958 215
VWAP
Ylin
0,32Alin
0,296VaihtoMäärä
1,5 4 958 215
Välittäjätilasto
Dataa ei löytynyt